Affinity Asset Advisors
4 posts
Kurome Therapeutics Closes $15 Million Series A Financing to Develop Targeted Kinase Inhibitors for Treatment of Hematopoietic Cancers
Financing Co-led by Medicxi and Affinity Asset Advisors
businesswire.com/news/home/2021…
English